Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127413521 | 12741352 | 1 | I | 201608 | 20160909 | 20160914 | 20160914 | PER | US-PFIZER INC-2016426629 | PFIZER | 69.00 | YR | F | Y | 121.00000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127413521 | 12741352 | 1 | PS | GLIPIZIDE XL | GLIPIZIDE | 1 | Oral | 10 MG, DAILY, ONE TABLET | N | 20329 | 10 | MG | GASTRO-RESISTANT TABLET | ||||||
| 127413521 | 12741352 | 2 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, 2X/DAY, [METFORMIN HYDROCHLORIDE 500 MG]/[ SITAGLIPTIN PHOSPHATE MONOHYDRATE 50 MG] | 0 | 1 | DF | TABLET | BID | ||||||
| 127413521 | 12741352 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 2.5 MG, 1X/DAY, ONE TABLET | 0 | 2.5 | MG | TABLET | QD | ||||||
| 127413521 | 12741352 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, 1X/DAY, ONE TABLET | 0 | 40 | MG | TABLET | QD | ||||||
| 127413521 | 12741352 | 5 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 150 MG, 1X/DAY, 75MG TWO TABLET | 0 | 150 | MG | TABLET | QD | ||||||
| 127413521 | 12741352 | 6 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 1 DF, AS NEEDED, 5-325MG | 0 | 1 | DF | TABLET | |||||||
| 127413521 | 12741352 | 7 | C | OMEGA 3 /01334101/ | OMEGA-3 FATTY ACIDS | 1 | Oral | 1 DF, 2X/DAY | 0 | 1 | DF | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127413521 | 12741352 | 1 | Diabetes mellitus |
| 127413521 | 12741352 | 2 | Diabetes mellitus |
| 127413521 | 12741352 | 3 | Hypertension |
| 127413521 | 12741352 | 4 | Blood cholesterol abnormal |
| 127413521 | 12741352 | 5 | Coagulopathy |
| 127413521 | 12741352 | 6 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127413521 | 12741352 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127413521 | 12741352 | Blood glucose increased | |
| 127413521 | 12741352 | Body height decreased | |
| 127413521 | 12741352 | Constipation | |
| 127413521 | 12741352 | Expired product administered | |
| 127413521 | 12741352 | Malabsorption | |
| 127413521 | 12741352 | Medication residue present | |
| 127413521 | 12741352 | Product physical issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127413521 | 12741352 | 1 | 201608 | 0 |